Key result
Meta Salud Diabetes behavioral intervention shows feasibility and trending HbA1c reductions in Hispanic patients.
Why the study?
Hispanics experience a disproportionate burden of T2D and CVD, warranting the evaluation of culturally appropriate behavioral health interventions in resource-scarce health systems.
Does the Meta Salud Diabetes behavioral intervention improve feasibility and clinical risk factors in Hispanic patients with type-2 diabetes?
Does the Meta Salud Diabetes behavioral intervention improve feasibility and clinical risk factors in Hispanic patients with type-2 diabetes?
A culturally tailored 13-week behavioral intervention is feasible and may improve glycemic and cardiovascular risk factors in Hispanic patients with type-2 diabetes.
Supports culturally tailored behavioral interventions in Hispanic diabetes patients; leaves open efficacy on glycemic control pending randomized trials.
Background: Hispanics in the United States experience a greater burden of type-2 diabetes (T2D), with a prevalence rate (17%) more than twice that of non-Hispanic whites (8%). Cardiovascular disease (CVD) is the leading cause of death among people with T2D. A culturally appropriate behavioral health intervention that addresses healthy lifestyle promotion is an impactful approach for health systems with scarce medical resources and a high prevalence of chronic conditions, including obesity and high blood pressure, which increase the likelihood of CVD mortality among type-2 diabetics. Purpose: To assess the feasibility and outcomes of a behavioral intervention to decrease CVD and complications in a Hispanic diabetic population. Methods: Meta Salud Diabetes (MSD), a behavioral intervention effective in a Mexican population, consists of a 13-week intervention addressing CVD and T2D knowledge and risk reduction. It was implemented in a sample of Hispanic diabetic patients from two federally qualified health centers (FQHCs). Clinical and behavioral variables were measured at baseline, postintervention, and 1-year follow-up. Results: The feasibility of MSD was rated as successful by all FQHC staff and well-received by both staff and study participants, with positive remarks about the culturally relevant components of the intervention. The sample size was n = 30 (baseline), n = 23 (postintervention), and n = 19 (1-year follow-up). Of note, quantitative results showed trending decreases in Hba1c (7.06; 6.80; 6.30), blood pressure (132/83; 126/80; 123/78), and total cholesterol (160; 159; 154). Conclusion: MSD is a feasible intervention and can address the need to improve health outcomes among Hispanic patients with T2D.
No takes yet. Share an insight, caveat, or question.
Nuño et al. (2023) studied Type-2 Diabetes (n=30). Meta Salud Diabetes (MSD) behavioral intervention was evaluated on Feasibility and clinical outcomes (HbA1c, blood pressure, total cholesterol). The Meta Salud Diabetes behavioral intervention was feasible in Hispanic patients with type-2 diabetes, showing trending decreases in HbA1c from 7.06 to 6.30 over a 1-year follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: